Genetics Core
Genetics Core
批准号:
8379365
负责人:
ROBERT DAVID SCHREIBER
金额:
$23.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2016-08-31
关键词:
AllelesBackcrossingsBioinformaticsCommunitiesCore FacilityCustomDevelopmentGeneticGenetic ServicesGenomicsGenotypeGrowthHumanKnockout MiceMicroinjectionsMouse StrainsMusProteinsResearchResearch PersonnelRheumatismServicesSpeedTechniquesTestingTransgenic MiceTransgenic OrganismsUniversitiesWashingtoncongenicdesignembryonic stem cellmembertool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Genetics Core facility is one of the research cores in the Rheumatic Diseases Core Center (RDCC) at Washington University. It proposes the following Specific Aims to sustain and develop new state-of-the-art protein services to RDCC members: 1) Support continued progress and growth of the Transgenic and Knockout Mouse Facility; 2) Support continued progress and growth of the mouse Speed Congenics Facility; and 3) Support development and use of a new Human Genomics and Bioinformatics Facility. The Transgenic and Knockout Mouse Facility helps RDCC investigators produce new strains of mice by microinjection of transgenic constructs or embryonic stem cells. The Speed Congenics Facility provides custom genotyping to speed backcrossing of mice with defined alleles onto homogeneous genetic backgrounds. The new Human Genomics and Bioinformatics Facility will provide expertise in design and interpretation of high throughput genetics information. All units are devoted to testing new techniques in order to provide the RDCC community with new tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
-
批准号:8887618
-
项目类别:
-
资助金额:$46.91万
-
财政年份:2015
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
-
批准号:9031745
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2015
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
-
批准号:8234935
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2011
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tumor Immunology Program
-
批准号:8181178
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2010
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tissue specific role of IFNalpha/beta and IFNgamma in innate immuniy to prio path
-
批准号:7672130
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2009
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Genetic Core
-
批准号:7667781
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2008
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Genetic Core
-
批准号:7485263
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2007
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:6771282
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:7215633
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:6888072
-
项目类别:
-
资助金额:$47.99万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Jaks and Stats: Development to Disease
-
批准号:6789526
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:7028854
-
项目类别:
-
资助金额:$40.64万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
The Molecular and Cellular Basis of Cancer Immunoediting
-
批准号:7361384
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
Tumor Immunology Program
-
批准号:6998150
-
项目类别:
-
资助金额:$2.03万
-
财政年份:2004
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:6718020
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:6984102
-
项目类别:
-
资助金额:$41.32万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:6833471
-
项目类别:
-
资助金额:$41.01万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:7325725
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
IL-10 Receptor Signaling That Regulates Innate Immunity
-
批准号:7151927
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2003
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位:
INTERFERON GAMMA SIGNALING DEFECTS IN TUMOR EVASION
-
批准号:6563893
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2001
-
负责人:ROBERT DAVID SCHREIBER
-
依托单位: